FDA Approved: TYVASO DPI — Original Application (United Therapeutics Corporation)

View source ↗

Summary

FDA approves TYVASO DPI as an Original Application, introducing a dry powder inhalation formulation of treprostinil from United Therapeutics. The product is ind…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• TYVASO DPI (Treprostinil)

Snippet

ORIG AP for TYVASO DPI (TREPROSTINIL)